ApprovalTrail

Company · St. Laurent, Quebec, Canada

Wyeth Canada

Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.

Drug products (DIN)
35
0 authorized now
Natural health products
0
0 active licences
Medical device licences
0
0 active
Notices of Compliance
68

Drug products

Authorized products first.

NameDINStatus
AMICAR - TAB, 500MG02169754Cancelled Post Market
AMICAR INJECTION - LIQ IV 250MG/ML02169746Cancelled Post Market
ATIVAN INJECTION LIQ 4MG/ML02041405Cancelled Post Market
AURALGAN EARDROPS02041502Cancelled Post Market
BEMINAL 500 TABS02047225Cancelled Post Market
BENEFIX - (250IU)02231018Cancelled Post Market
BENEFIX - (500IU)02231019Cancelled Post Market
BENEFIX -(1000IU)02231020Cancelled Post Market
CEFOTAN INJECTION - 1G02036274Cancelled Post Market
CEFOTAN INJECTION - 2 G02036428Cancelled Post Market
CORONEX02041715Cancelled Post Market
CORONEX02041723Cancelled Post Market
CORONEX 5MG SUBLINGUAL TABLETS02044811Cancelled Post Market
DECLOMYCIN02169924Cancelled Post Market
DIAMOX SEQUELS02238073Cancelled Post Market
EFFEXOR TABLETS, 37.5MG02103680Cancelled Post Market
EFFEXOR TABLETS, 50MG02103699Cancelled Post Market
EFFEXOR TABLETS, 75MG02103702Cancelled Post Market
MONITAN 10002036290Cancelled Post Market
MONITAN 20002036436Cancelled Post Market
MONITAN 40002036444Cancelled Post Market
NOVANTRONE02173468Cancelled Post Market
OS-CAL 250 MG02042983Cancelled Post Market
OS-CAL 50002042991Cancelled Post Market
OS-CAL-D 50002043025Cancelled Post Market
OVRAL 28 TABLETS02043041Cancelled Post Market
PIPRACIL-PWS IM IV 4G/VIAL02173441Cancelled Post Market
PIPRACIL-PWS IV IM 2G/VIAL02173425Cancelled Post Market
PIPRACIL-PWS IV IM 3G/VIAL02173433Cancelled Post Market
PREMARIN TABLETS 0.9MG02043416Cancelled Post Market
PROTOPAM CHLORIDE - (PWS 1G/VIAL)02043475Cancelled Post Market
REFACTO02245951Cancelled Post Market
THIOTEPA - (PWS 15 MG/VIAL)02174391Cancelled Post Market
TRIPHASIL 2102043726Cancelled Post Market
TRIPHASIL 2802043734Cancelled Post Market

Notices of Compliance

Newest first.

  • RELISTOR; RELISTOR (8MG/0.4ML PRE FILLED SYRINGE, SINGLE USE); RELISTOR (12MG/0.6ML PRE FILLED SYRINGE, SINGLE USE)September 17, 2010 · NOC 11717 · Supplement to a New Drug Submission (SNDS)
  • PREVNAR 13December 21, 2009 · NOC 10873 · New Drug Submission (NDS)
  • PREVNARApril 21, 2009 · NOC 10169 · Supplement to a New Drug Submission (SNDS)
  • ALESSE 21; ALESSE 28February 10, 2009 · NOC 10034 · Supplement to a New Drug Submission (SNDS)
  • PRISTIQFebruary 4, 2009 · NOC 10026 · New Drug Submission (NDS)
  • TYGACILOctober 23, 2008 · NOC 9846 · Supplement to a New Drug Submission (SNDS)
  • PREVNARSeptember 23, 2008 · NOC 9793 · Supplement to a New Drug Submission (SNDS)
  • TAZOCINAugust 25, 2008 · NOC 9734 · Supplement to a New Drug Submission (SNDS)
  • EFFEXOR XRJune 20, 2008 · NOC 9636 · Supplement to a New Drug Submission (SNDS)
  • XYNTHAApril 23, 2008 · NOC 9503 · Supplement to a New Drug Submission (SNDS)
  • RELISTORMarch 28, 2008 · NOC 9445 · New Drug Submission (NDS)
  • TORISELDecember 21, 2007 · NOC 9263 · New Drug Submission (NDS)
  • RAPAMUNENovember 29, 2007 · NOC 9212 · Supplement to a New Drug Submission (SNDS)
  • BELESSE 21; BELESSE 28October 16, 2007 · NOC 9099 · New Drug Submission (NDS)
  • MENINGITECAugust 13, 2007 · NOC 8971 · Supplement to a New Drug Submission (SNDS)
  • STARNOCJuly 18, 2007 · NOC 8916 · New Drug Submission (NDS)
  • MENINGITECJune 26, 2007 · NOC 8865 · Supplement to a New Drug Submission (SNDS)
  • BENEFIXApril 13, 2007 · NOC 8706 · Supplement to a New Drug Submission (SNDS)
  • OVRAL 21March 27, 2007 · NOC 8678 · Supplement to a New Drug Submission (SNDS)
  • RAPAMUNEMarch 23, 2007 · NOC 8665 · Supplement to a New Drug Submission (SNDS)
  • CORDARONEFebruary 15, 2007 · NOC 8591 · Supplement to a New Drug Submission (SNDS)
  • TYGACILSeptember 14, 2006 · NOC 8265 · New Drug Submission (NDS)
  • RAPAMUNEAugust 25, 2006 · NOC 8225 · Supplement to a New Drug Submission (SNDS)
  • PREVNARJuly 24, 2006 · NOC 8163 · Supplement to a New Drug Submission (SNDS)
  • PREMPLUS; PREMPLUS CYCLEJune 26, 2006 · NOC 8074 · Supplement to a New Drug Submission (SNDS)
  • METHOTREXATEDecember 22, 2005 · NOC 7667 · Supplement to a New Drug Submission (SNDS)
  • PREVNARSeptember 20, 2005 · NOC 7408 · Supplement to a New Drug Submission (SNDS)
  • EFFEXOR XRSeptember 1, 2005 · NOC 7343 · Supplement to a New Drug Submission (SNDS)
  • RAPAMUNEAugust 29, 2005 · NOC 7333 · Supplement to a New Drug Submission (SNDS)
  • RAPAMUNEAugust 29, 2005 · NOC 7334 · Supplement to a New Drug Submission (SNDS)
  • CORDARONEAugust 18, 2005 · NOC 7309 · Supplement to a New Drug Submission (SNDS)
  • TAZOCINMay 13, 2005 · NOC 6726 · Supplement to a New Drug Submission (SNDS)
  • EFFEXOR XRDecember 10, 2004 · NOC 5986 · Supplement to a New Drug Submission (SNDS)
  • EFFEXOR XRSeptember 13, 2004 · NOC 5359 · Supplement to a New Drug Submission (SNDS)
  • REFACTOJuly 7, 2004 · NOC 4788 · Supplement to a New Drug Submission (SNDS)
  • RAPAMUNEMay 28, 2004 · NOC 3081 · Supplement to a New Drug Submission (SNDS)
  • MENINGITECDecember 12, 2003 · NOC 1784 · New Drug Submission (NDS)
  • PREMPLUS TABLETS; PREMPLUS CYCLE TABLETSNovember 25, 2003 · NOC 411 · Supplement to a New Drug Submission (SNDS)
  • EFFEXOR XRJune 13, 2003 · NOC 3538 · Supplement to a New Drug Submission (SNDS)
  • TAZOCINMay 20, 2003 · NOC 3466 · New Drug Submission (NDS)
  • CORDARONEMay 12, 2003 · NOC 81 · New Drug Submission (NDS)
  • INDERAL-LAMay 12, 2003 · NOC 3467 · New Drug Submission (NDS)
  • OVRAL 21; OVRAL 28May 8, 2003 · NOC 3403 · New Drug Submission (NDS)
  • EFFEXOR; EFFEXOR XRApril 25, 2003 · NOC 3540 · Supplement to a New Drug Submission (SNDS)
  • THIOTEPAApril 23, 2003 · NOC 3617 · New Drug Submission (NDS)
  • AMICARApril 14, 2003 · NOC 85 · New Drug Submission (NDS)
  • LO-FEMENAL 21; LO-FEMENAL 28April 9, 2003 · NOC 3405 · New Drug Submission (NDS)
  • BENEFIXApril 8, 2003 · NOC 401 · New Drug Submission (NDS)
  • PREVNARApril 8, 2003 · NOC 3579 · New Drug Submission (NDS)
  • THRIPHASIL 21; TRIPHASIL 28April 7, 2003 · NOC 1716 · New Drug Submission (NDS)
  • METHOTREXATEApril 7, 2003 · NOC 2857 · New Drug Submission (NDS)
  • PIPRACILApril 7, 2003 · NOC 3469 · New Drug Submission (NDS)
  • PREMPLUS; PREMPLUS CYCLEApril 3, 2003 · NOC 408 · New Drug Submission (NDS)
  • MONITANApril 2, 2003 · NOC 87 · New Drug Submission (NDS)
  • PREMELLEApril 2, 2003 · NOC 412 · New Drug Submission (NDS)
  • CEFOTANApril 2, 2003 · NOC 419 · New Drug Submission (NDS)
  • CORONEXApril 2, 2003 · NOC 1487 · New Drug Submission (NDS)
  • MIN-OVRAL 21; MIN-OVRAL 28April 2, 2003 · NOC 1717 · New Drug Submission (NDS)
  • LEDERLE LEUCOVORINApril 2, 2003 · NOC 1718 · New Drug Submission (NDS)
  • ATIVANApril 2, 2003 · NOC 1719 · New Drug Submission (NDS)
  • ALESSE 21; ALESSE 28April 2, 2003 · NOC 1720 · New Drug Submission (NDS)
  • NOVANTRONEApril 2, 2003 · NOC 2858 · New Drug Submission (NDS)
  • MEPROGESTApril 2, 2003 · NOC 2859 · New Drug Submission (NDS)
  • OVRETTEApril 2, 2003 · NOC 3406 · New Drug Submission (NDS)
  • EFFEXOR; EFFEXOR XRMarch 14, 2003 · NOC 3541 · New Drug Submission (NDS)
  • REFACTOMarch 11, 2003 · NOC 2862 · New Drug Submission (NDS)
  • RAPAMUNEMarch 10, 2003 · NOC 3580 · New Drug Submission (NDS)
  • LOETTE 21 TABLETS; LOETTE 28 TABLETSFebruary 6, 2003 · NOC 1743 · New Drug Submission (NDS)